📢 Live Market News: Loading news...

Hyperliquid Strategies Files $1 Billion Raise to Buy More HYPE


Hyperliquid Strategies is doubling down on its plan for Hyperliquid Treasury, filing paperwork to raise up to $1 billion to purchase more tokens that power the world's largest decentralized derivatives platform.

According to its S-1 registration statement with the U.S. Securities and Exchange Commission on Wednesday, Hyperliquid Strategies disclosed its plan to offer up to 160 million shares of common stock to fund additional Hyperliquid (HYPE) purchases as well as other company expenses.

Chardan Capital Markets is acting as financial advisor to the offering.

source: Cointelegraph

Hyperliquid Strategies is a pending merger entity formed by Nasdaq-listed biotechnology company Sonnet BioTherapeutics and special purpose acquisition company Rorschach I LLC.

The combined entity will be led by David Shamis as CEO and Bob Diamond, former CEO of Barclays Bank, who will serve as Chairman.

The news also appears to have sparked a roughly 8% rally in the HYPE token to $37.73 over the past 24 hours, while the broader cryptocurrency market fell 0.6%, CoinGecko data shows.

Hyperliquid Strategies is positioned to lead the HYPE race

When the merger closes, Hyperliquid Strategies is expected to own 12.6 million HYPE tokens – currently worth around $470 million, while holding another $305 million in cash.

CoinGecko data also showed that the $305 million is also intended to buy more HYPE tokens, which would easily make Hyperliquid Strategies the largest HYPE holder.